The Next Frontier in HIV Innovation: the Transition to No Transmission

4:30 PM - 5:30 PM, Tuesday, June 9, 2020 ・ Room 7B
In its 40-year lifetime, the HIV epidemic has shifted from a death sentence to a manageable condition thanks to life-saving medical advances. Despite this progress, unmet needs still exist and the scientific innovation must continue to advance. With unprecedented possibilities for scientific breakthroughs, now is the time to address the real needs of tomorrow.

During this session, experts will discuss key areas influencing the future of the HIV epidemic, including the need for meaningful biopharma innovation to address unmet needs, breakthrough R&D for today and tomorrow, and public health solutions and political will to drive change and stop spread of epidemic.

With the right combination of commitment, actionable stakeholder mobilization, innovation, infrastructure, political will and education, we can tackle the spread of the epidemic.
Moderator
photo
Science Journalist
Speakers
photo
Executive Vice President & Chief Patient Officer
Merck & Co, Inc.
photo
Director, Joseph W. Blount Center for Health and Human Rights
Emory University
photo
Executive Director
AVAC